The COVID-19 outbreak is putting considerable strain on medical treatment in Taiwan. A good way to reduce the workload of healthcare and disease prevention personnel would be to let machines do any jobs that do not need a human.
A final diagnosis of COVID-19 is made based on the results of a person’s polymerase chain reaction (PCR) test, which takes three to four hours when done by hand. A rise in screening volume pushes facilities to increase testing capacity — more equipment, more personnel and longer working hours — which greatly increases the screening staff’s risk of infection. If the tests were automated, it would reduce the risk of infection, as well as boosting testing capacity.
In April last year, TCI Gene and the Ministry of Health and Welfare launched the Quantitative Virus Scanner-96 (QVS-96) — Taiwan’s first automated testing device for SARS-CoV-2, which causes COVID-19.
The QVS-96, which sells for US$700,000, is reported to be the second such device in the world. It can operate around the clock, conducting 900 tests per day with 99.9 percent accuracy.
Media reports at the time said that the virus scanner had been validated by the Centers for Disease Control and would be used in the agency’s Kunyang Laboratory, adding that satisfactory performance would see the scanner installed elsewhere, depending on the COVID-19 situation, and would improve testing efficiency during the flu season.
Reports last month said that TCI Gene had suspended the planned export of two QVS-96S virus scanners, with a daily testing capacity of 1,900 tests, and that the company had joined the national disease prevention team.
In December last year, LabTurbo Biotech and the National Defense Medical Center’s Institute of Preventive Medicine finished developing the LabTurbo AIO 48 — a fully automated testing device capable of conducting 1,000 tests per day.
These developments show that the nation’s biotechnology industry has had great success at boosting testing capacity.
As of March 31 last year, Taiwan had four testing and treatment facilities, which could conduct 3,200 COVID-19 tests per day. On May 15 this year, the Central Epidemic Command Center said that there were 126 such facilities, capable of conducting 16,000 tests per day. The ratio of centers to tests shows that the increase in testing capacity has mainly been achieved by increasing the number of testing facilities.
As the QVS-96 seems to have only been installed at the Kunyang Laboratory and one private facility, Landseed International Hospital in Taoyuan, it is difficult to see what kind of advanced approach the government might be deploying to boost screening capacity.
Taiwan makes sophisticated instruments that have been certified in the US and European nations, so why not allocate NT$200 million (US$7.24 million) of the NT$630 billion COVID-19 relief budget to purchase 10 automated virus scanners?
This would give the nation a daily testing capacity of 19,000 tests.
Such an investment would provide real relief for all of the disease prevention personnel, who have been working hard day and night on screening and contact tracing, and help to maintain adequate healthcare capacity for patients who need it. It would also allow local governments to put people’s minds at rest by speeding up the screening process.
Liu Te-yen is a student at National Sun Yat-sen University’s Graduate Institute of Marine Affairs.
Translated by Julian Clegg
Could Asia be on the verge of a new wave of nuclear proliferation? A look back at the early history of the North Atlantic Treaty Organization (NATO), which recently celebrated its 75th anniversary, illuminates some reasons for concern in the Indo-Pacific today. US Secretary of Defense Lloyd Austin recently described NATO as “the most powerful and successful alliance in history,” but the organization’s early years were not without challenges. At its inception, the signing of the North Atlantic Treaty marked a sea change in American strategic thinking. The United States had been intent on withdrawing from Europe in the years following
My wife and I spent the week in the interior of Taiwan where Shuyuan spent her childhood. In that town there is a street that functions as an open farmer’s market. Walk along that street, as Shuyuan did yesterday, and it is next to impossible to come home empty-handed. Some mangoes that looked vaguely like others we had seen around here ended up on our table. Shuyuan told how she had bought them from a little old farmer woman from the countryside who said the mangoes were from a very old tree she had on her property. The big surprise
The issue of China’s overcapacity has drawn greater global attention recently, with US Secretary of the Treasury Janet Yellen urging Beijing to address its excess production in key industries during her visit to China last week. Meanwhile in Brussels, European Commission President Ursula von der Leyen last week said that Europe must have a tough talk with China on its perceived overcapacity and unfair trade practices. The remarks by Yellen and Von der Leyen come as China’s economy is undergoing a painful transition. Beijing is trying to steer the world’s second-largest economy out of a COVID-19 slump, the property crisis and
Former president Ma Ying-jeou’s (馬英九) trip to China provides a pertinent reminder of why Taiwanese protested so vociferously against attempts to force through the cross-strait service trade agreement in 2014 and why, since Ma’s presidential election win in 2012, they have not voted in another Chinese Nationalist Party (KMT) candidate. While the nation narrowly avoided tragedy — the treaty would have put Taiwan on the path toward the demobilization of its democracy, which Courtney Donovan Smith wrote about in the Taipei Times in “With the Sunflower movement Taiwan dodged a bullet” — Ma’s political swansong in China, which included fawning dithyrambs